ACIU · NASDAQ · Biotechnology

AC Immune (ACIU)

Develops protein-misfolding therapies and diagnostics for neurodegenerative diseases.

$2.73
After hours−0.01 (−0.36%)
At close$2.74(+3.20%)
  1. AC Immune (ACIU) Upgraded to Buy: Here's Why

    Zacks Investment Research